Rchr
J-GLOBAL ID:200901017441552554   Update date: Jan. 30, 2024

Kajino Kazunori

カジノ カズノリ | Kajino Kazunori
Affiliation and department:
Job title: Associate Professor
Research field  (2): Gastroenterology ,  Experimental pathology
Research keywords  (5): mesothelin ,  中皮腫 ,  ERC ,  肝発がん ,  ゲノム不安定性
Research theme for competitive and other funds  (10):
  • 2011 - 2013 Comprehensive molecular and pathological analysis of Mesothelin expression
  • 2010 - 2012 A role of dbpA, DNA binding protein in Hodgkin lymphoma
  • 2005 - 2009 The study of multistep carcinogenesis using unique animal models
  • 2006 - 2007 Role of dbpA in hepatocarcinogenesis
  • 2004 - 2005 Molecular mechanism of hypercarcinogenic state -inflammation-induced hepatocarcinogenesis-
Show all
Papers (63):
  • Gentaro Taniguchi, Kazunori Kajino, Shuji Momose, Harumi Saeki, Liang Yue, Naomi Ohtsuji, Masaaki Abe, Tomoyoshi Shibuya, Akira Orimo, Akihito Nagahara, et al. The Inhibitory Effects of Anti-ERC/Mesothelin Antibody 22A31 on Colorectal Adenocarcinoma Cells, within a Mouse Xenograft Model. Cancers. 2022. 14. 9
  • Tadaaki Inano, Hajime Yasuda, Yutaka Tsukune, Miyuki Tsutsui, Nadila Wali, Harumi Saeki, Kazunori Kajino, Okio Hino, Yasufumi Masaki, Norio Komatsu. Abnormal Exacerbation of Moderately Differentiated Gastric Adenocarcinoma in a Patient with TAFRO Syndrome: An Impaired Tumor Immunity?. Case Reports in Oncology. 2022. 15. 1. 7-11
  • Haruhiko Fujihira, Daisuke Takakura, Atsushi Matsuda, Masaaki Abe, Michiyo Miyazaki, Tomomi Nakagawa, Kazunori Kajino, Kaori Denda-Nagai, Miki Noji, Okio Hino, et al. Bisecting-GlcNAc on Asn388 is characteristic to ERC/mesothelin expressed on epithelioid mesothelioma cells. Journal of biochemistry. 2021
  • Natsuko Mizutani, Masaaki Abe, Kazunori Kajino, Shuji Matsuoka. A New CD10 Antibody Inhibits the Growth of Malignant Mesothelioma. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2021. 40. 1. 21-27
  • Bo Han, Hyeon-Cheol Lee-Okada, Momoko Ishimine, Hajime Orita, Keiko Nishikawa, Tetsuya Takagaki, Kazunori Kajino, Takehiko Yokomizo, Okio Hino, Toshiyuki Kobayashi. Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells. FEBS Open Bio. 2020. 10. 11. 2375-2387
more...
MISC (212):
Education (4):
  • - 1990 Ehime University
  • - 1990 Ehime University Graduate School, Division of Medicine
  • - 1981 Ehime University School of Medicine
  • - 1981 Ehime University Faculty of Medicine
Professional career (1):
  • (BLANK) (Ehime University)
Work history (6):
  • 2017 - 現在 Juntendo University Faculty of Medicine
  • 2007 - 2016 Juntendo University Faculty of Medicine
  • 2004 - 2006 Juntendo University Faculty of Medicine
  • 1993 - - (財)癌研究会癌研究所 研究員
  • 1993 - - Associate, Cancer Institute(JFCR)
Show all
Association Membership(s) (5):
日本分子生物学会 ,  日本癌学会 ,  日本内科学会 ,  日本肝臓学会 ,  日本病理学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page